The Ultimate Guide to Cabergoline: Chemical Profile, Compositions, and Wholesale Sourcing

In the highly specialized fields of endocrinology, neurology, and advanced performance pharmacology, few compounds are as precisely targeted—and as fiercely debated—as cabergoline. Universally recognized by its pioneer brand name Dostinex, this potent, long-acting dopamine receptor agonist is the undisputed clinical gold standard for the management of hyperprolactinemia (elevated prolactin levels).

Whether it is being utilized to shrink life-altering pituitary prolactinomas, restoring fertility in both men and women suffering from hypogonadism, or serving as the critical “rescue” agent for bodybuilders combatting the devastating prolactin-induced side effects of 19-nor anabolic steroids (like Trenbolone and Nandrolone), cabergoline is an indispensable pharmacological tool.

For bulk buyers, research facilities, compounding pharmacies, and supply chain managers, understanding the intricate pharmacological, chemical, and logistical nuances of cabergoline is paramount. Because it operates directly on the dopaminergic system of the brain and exerts systemic effects on the cardiovascular and endocrine systems, there is zero margin for error in its synthesis, formulation, and quality control.

At Wholesale China Peptides (https://wholesalechinapeptides.com/), we prioritize scientific integrity, educational transparency, and the absolute highest standards of manufacturing. This comprehensive 3500+ word guide will exhaustively explore every facet of cabergoline—from its clinical origins and complex chemical architecture to its mechanisms of action, clinical and performance benefits, severe risk profiles, and the critical protocols required for sourcing wholesale cabergoline safely and effectively.

---

Chapter 1: The History and Origins of Cabergoline

The story of cabergoline is one of pharmacological refinement. For decades, the primary treatment for hyperprolactinemia was Bromocriptine (Parlodel), an ergot-derived dopamine agonist. While effective, Bromocriptine was notorious for its horrific side-effect profile. Because it was a non-selective agonist that hit multiple serotonin and adrenergic receptors in addition to dopamine D2 receptors, patients suffered from severe nausea, orthostatic hypotension (dizziness upon standing), vomiting, and headaches. Furthermore, its short half-life required multiple daily doses, leading to poor patient compliance.

In the 1980s, researchers at Pharmacia & Upjohn (now part of Pfizer) initiated a drug discovery program seeking a “next-generation” dopamine agonist. Their goals were clear: maximal selectivity for the D2 receptor, an exceptionally long biological half-life to allow for once- or twice-weekly dosing, and a drastic reduction in peripheral side effects.

Through structural modifications of the ergot alkaloid skeleton, they synthesized a series of carbergoline derivatives. One compound proved remarkably superior. It exhibited an extraordinarily high affinity and selectivity for the dopamine D2 receptor, while showing minimal activity at D1, serotonin, and adrenergic receptors. Furthermore, due to its unique structural composition, it demonstrated a terminal half-life of over 60 hours in humans.

This compound was cabergoline. Approved by the FDA in 1996 under the brand name Dostinex, it revolutionized the treatment of prolactin disorders. Its convenient twice-weekly dosing and vastly superior tolerability quickly relegated Bromocriptine to a second-line therapy.

Simultaneously, as the use of 19-nor anabolic steroids (Nandrolone/Deca-Durabolin and Trenbolone) surged in the bodybuilding community, athletes discovered a new problem: these steroids aggressively stimulated prolactin receptors, leading to conditions like “Deca Dick” (severe erectile dysfunction and loss of libido) and lactation (galactorrhea) in males. cabergoline was rapidly adopted as the ultimate defense, capable of crushing prolactin levels and restoring sexual function, cementing its legacy across both clinical medicine and performance enhancement.

---

Chapter 2: Chemical Information and Compositions of Cabergoline

For researchers, biochemists, and wholesale distributors, the molecular structure of cabergoline is a masterclass in targeted receptor selectivity and metabolic stability. Understanding its composition is vital for analytical testing, formulation, and predicting its biological behavior.

Official Chemical Nomenclature

• Chemical Name: (8R)-N-[(3-dimethylamino)propyl]-N-[(ethylcarbamoyl)methyl]-10-methoxy-6-methylergoline-8-carboxamide
• Chemical Formula: C26H29N5O2
• Molecular Weight: 451.60 g/mol
• CAS Number: 81409-02-5

Structural Composition Breakdown

cabergoline is a semi-synthetic ergot alkaloid derivative. Its structural architecture is what gives it its phenomenal D2 selectivity and ultra-long half-life:

1. The Ergoline Ring System: The core of the molecule features the classic tetracyclic ergoline ring system (shared with Bromocriptine and LSD), which is essential for binding to the dopaminergic receptors.
2. The C-10 Methoxy Group: The presence of a methoxy group (-OCH3) at the 10th carbon position is critical. This electron-donating group fine-tunes the stereochemistry and electron density of the molecule, drastically increasing its affinity for the dopamine D2 receptor while decreasing its affinity for D1 and serotonin receptors, reducing hallucinations and nausea.
3. The C-8 Carboxamide Side Chain: The highly polar, bulky N-[(3-dimethylamino)propyl]-N-[(ethylcarbamoyl)methyl] carboxamide side chain at the 8th carbon is the defining structural feature of cabergoline. This side chain contributes massively to the molecule’s metabolic stability. It protects the molecule from rapid hepatic first-pass degradation by cytochrome P450 enzymes, which is the primary reason for its 60+ hour half-life.
4. Stereochemistry: cabergoline has a chiral center at the 8th carbon (8R configuration). Only this specific stereoisomer possesses the desired dopaminergic activity; the 8S enantiomer is largely inert.

Physical and Chemical Properties

• State at Room Temperature: Solid (Crystalline Powder)
• Color: White to off-white
• Solubility: Practically insoluble in water (0.039 mg/mL). Highly soluble in organic solvents such as DMSO, ethanol, methanol, and ethyl acetate. Due to its poor aqueous solubility, it requires specific pharmaceutical excipients for oral bioavailability.
• Melting Point: Approximately 102°C to 104°C.

Pharmacokinetics

• Route of Administration: Oral
• Absorption: Rapidly absorbed from the gastrointestinal tract. Food does not significantly alter the extent of absorption, though taking it with a meal can mitigate initial nausea.
• Half-Life: The pharmacokinetic profile of cabergoline is defined by its ultra-long terminal elimination half-life, which ranges from 60 to 65 hours (roughly 2.5 to 3 days) in healthy individuals, and can extend up to 100 hours in hyperprolactinemic patients. This allows for convenient twice-weekly (or even once-weekly) dosing.
• Metabolism: Extensively metabolized in the liver, primarily via hydrolysis of the acylurea bond and N-dealkylation.
• Excretion: Excreted mainly in the feces (both as unchanged drug and metabolites), with a small fraction (3-6%) excreted in the urine.

Formulation Details: The Pill

When you source wholesale cabergoline, you are dealing with a micro-dose formulation. Standard clinical pills contain 0.5mg of the active API.

Because 0.5mg is an incredibly small mass, it must be geometrically diluted with excipients to create a handleable, uniform pill. Standard excipients include:

• Lactose Monohydrate: Diluent/filler to add necessary bulk.
• Microcrystalline Cellulose (MCC): Binder and filler for structural integrity.
• Croscarmellose Sodium: Super-disintegrant for rapid dissolution.
• Povidone (PVP): Binder.
• Magnesium Stearate: Lubricant to prevent sticking during tableting.

For B2B buyers, ensuring the uniform blending of 0.5mg of API within 100-200mg of these excipients is the single greatest manufacturing challenge. Failure results in “hot spots” (pills with 1.5mg) and “dead spots” (pills with 0mg), which are disastrous for endocrine management.

---

Chapter 3: Mechanism of Action: How Cabergoline Works

The pharmacodynamic behavior of cabergoline is distinct from AIs and SERMs. It targets the dopaminergic system to directly inhibit the secretion of prolactin.

The Dopamine D2 Receptor and Prolactin

Prolactin is a hormone produced by the lactotroph cells in the anterior pituitary gland. Its primary functions are stimulating breast milk production (lactation) and breast tissue development in women. However, prolactin also plays a massive role in suppressing the hypothalamic-pituitary-gonadal (HPG) axis. High prolactin drastically inhibits the release of Gonadotropin-Releasing Hormone (GnRH), which in turn shuts down the secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). Without LH and FSH, the testes and ovaries stop producing testosterone and estrogen, leading to hypogonadism, infertility, and loss of libido.

Crucially, the release of prolactin from the pituitary is under tonic inhibitory control by Dopamine. Dopamine, produced by the hypothalamus, travels down the portal vasculature to the pituitary, where it binds to Dopamine D2 receptors on the lactotroph cells. This binding tells the cell to stop producing prolactin.

Potent D2 Agonism

cabergoline acts as a potent, highly selective agonist at the Dopamine D2 receptors. When it enters the bloodstream and crosses the blood-brain barrier, it binds to these D2 receptors on the lactotroph cells, mimicking the action of endogenous dopamine—but with vastly greater potency and duration.

By chronically stimulating the D2 receptors, cabergoline sends an overwhelming inhibitory signal to the pituitary gland. The lactotroph cells halt the synthesis and secretion of prolactin, and prolactin levels in the blood plummet.

In patients with prolactinomas (benign tumors of the pituitary that autonomously secrete massive amounts of prolactin), cabergoline not only stops prolactin secretion but often induces tumor shrinkage (antiproliferative effect) by causing the tumor cells to undergo apoptosis (programmed cell death).

---

Chapter 4: Cabergoline in Clinical Medicine

The primary and most historic FDA-approved use of cabergoline is for the treatment of hyperprolactinemic disorders.

Treatment of Hyperprolactinemia

Hyperprolactinemia can be idiopathic (unknown cause) or caused by a pituitary adenoma (prolactinoma). Symptoms in women include galactorrhea (inappropriate milk production), amenorrhea (absence of menstrual periods), oligo-ovulation, infertility, and osteoporosis due to estrogen deprivation. Symptoms in men include impotence, decreased libido, oligospermia (low sperm count), and gynecomastia.

cabergoline is the first-line therapy. In clinical trials, it normalizes prolactin levels in approximately 80% to 90% of patients with microadenomas and 70% to 80% of patients with macroadenomas, vastly outperforming Bromocriptine.

Parkinson’s Disease (Off-Label/Secondary)

Because Parkinson’s disease is characterized by the death of dopamine-producing neurons in the substantia nigra, cabergoline can be used as a monotherapy or adjunct therapy to levodopa. By stimulating D2 receptors in the striatum, it helps restore dopaminergic tone, reducing tremors and rigidity. However, due to its long half-life and potential for valvulopathy (discussed in side effects), it is rarely a first-line Parkinson’s treatment today.

---

Chapter 5: Cabergoline in Performance Enhancement

While officially approved for pituitary disorders, the off-label use of cabergoline in the anabolic steroid community is prevalent, specifically regarding 19-nor steroids.

The 19-Nor Steroid Problem

Anabolic-androgenic steroids derived from 19-nortestosterone—primarily Nandrolone (Deca-Durabolin) and Trenbolone—are highly valued for their immense anabolic potency and joint-healing properties. However, they possess a unique structural trait: they are potent progestins.

Nandrolone and Trenbolone bind strongly to the progesterone receptor. Progesterone, in the presence of high estrogen, upregulates the expression of prolactin receptors in breast tissue. Furthermore, Trenbolone has been shown in in vitro studies to possess a moderate affinity for the pituitary D2 receptor, where it can act as an antagonist, blocking dopamine’s inhibitory signal and actually stimulating prolactin release.

The Devastating Side Effects of High Prolactin on Cycle

When a male bodybuilder runs Trenbolone or Nandrolone, prolactin levels can spike dramatically. This leads to:

1. Prolactin-Induced Gynecomastia: Unlike estrogenic gyno, progesterone/prolactin-induced gyno is characterized by rapid, painful lactating glandular tissue.
2. Severe Sexual Dysfunction (“Tren Dick” / “Deca Dick”): High prolactin destroys the neurochemical pathways required for arousal and orgasm. Men experience anorgasmia (inability to climax), massive loss of libido, and severe erectile dysfunction. This is often far more psychologically distressing than gynecomastia.

Cabergoline: The Prolactin Rescue

cabergoline is utilized concurrently with 19-nor steroids to keep prolactin in check. By aggressively stimulating the D2 receptors, cabergoline forces the pituitary to stop secreting prolactin, even in the presence of Trenbolone.

For the bodybuilder, this means:

• Prevention/Libration of Progestogenic Gyno: Breast tissue lactation is halted.
• Restoration of Libido and Sexual Function: By lowering prolactin, the neurochemical pathways for dopamine-driven arousal and orgasmic function are restored. Many users report that cabergoline actually enhances sexual pleasure and reduces the refractory period between orgasms, earning it a controversial reputation as a “lifestyle” drug.

---

Chapter 6: The Comprehensive Benefits of Cabergoline

The benefits of cabergoline are entirely dependent on the context of its application, but all stem from its potent dopaminergic agonism and prolactin suppression.

For Women (Clinical)

• Normalization of Prolactin: Stops inappropriate lactation (galactorrhea).
• Restoration of Fertility: Resumes normal ovulatory menstrual cycles, allowing for conception.
• Tumor Shrinkage: Non-invasively shrinks prolactin-secreting pituitary adenomas, often saving patients from transsphenoidal brain surgery.

For Men (Clinical)

• Restoration of Testosterone Production: By removing the prolactin-induced suppression on the HPG axis, endogenous testosterone and sperm production resume.
• Resolution of Hypogonadal Symptoms: Restores libido, erectile function, and muscle mass lost to hyperprolactinemia.

For Men (Performance Enhancement)

• Absolute Prevention of Progestogenic Gyno: Stops 19-nor steroid-induced lactation and breast tissue growth.
• Rescue of Sexual Function: Counters the libido-killing and erectile-dysfunction effects of Trenbolone and Deca-Durabolin.
• Enhanced Orgasmic Function: Low prolactin levels drastically reduce the male refractory period, enhancing sexual performance.

---

Chapter 7: Side Effects and Risk Management

While highly effective, cabergoline is not without significant risks. It is a powerful psychoactive compound that profoundly alters central and peripheral dopaminergic tone.

Common Side Effects (Dose-Dependent)

At lower doses (0.25mg to 0.5mg per week), cabergoline is generally well-tolerated. However, as doses increase, side effects become prevalent:

• Nausea and Gastrointestinal Distress: The most common side effect, resulting from stimulation of the chemoreceptor trigger zone (CTZ) in the brain. Taking the pill with a large meal before bed can mitigate this.
• Orthostatic Hypotension: A sudden drop in blood pressure upon standing, leading to dizziness or fainting. This is due to peripheral D2 receptor stimulation causing vasodilation.
• Headaches and Lethargy: Fluctuations in dopamine and prolactin levels often cause severe headaches and a feeling of profound mental fatigue or “brain fog.”

Severe Side Effects (Long-Term / High Dose)

• Cardiac Valvulopathy (The Critical Risk): This is the most dangerous side effect associated with cabergoline. At high doses (typically >3mg/day, used in Parkinson’s patients), the molecule acts as an agonist at the Serotonin 5-HT2B receptors located on the heart valves (specifically the mitral and aortic valves). Stimulation of 5-HT2B receptors causes the valve leaflets to proliferate, thicken, and become fibrotic. This leads to valvular regurgitation (blood leaking backward through the valve). While this risk is extremely low at the micro-doses used for hyperprolactinemia (0.5mg/week), it is a mandatory consideration for anyone sourcing or formulating the drug, and long-term bodybuilders must monitor their cardiac health.
• Impulse Control Disorders: Dopamine agonists are notorious for causing severe impulse control problems. By flooding the brain’s reward center with dopaminergic stimulation, cabergoline can trigger pathological gambling, hypersexuality, compulsive shopping, and binge eating in predisposed individuals. This risk is higher in bodybuilders using it recreationally for sexual enhancement.
• Psychiatric Symptoms: Hallucinations, paranoia, and delusions can occur, though this is rare at micro-doses and more common in Parkinson’s patients.

---

Chapter 8: Dosage Protocols and Administration

Designing an effective protocol for cabergoline requires strict adherence to micro-dosing principles. Because of its 65-hour half-life, the drug accumulates massively in the system. Guessing dosages leads to crashed prolactin, severe depression, and cardiac stress.

Medical Protocol (Hyperprolactinemia)

• Starting Dose: 0.25mg (half a pill) taken twice a week (e.g., Monday and Thursday).
• Maintenance Dose: Typically 0.5mg twice a week. Doses are increased only by 0.25mg increments at 4-week intervals until prolactin normalizes.
• Maximum Dose: 1mg twice a week (2mg total per week).

Performance Enhancement Protocol (On-Cycle with 19-Nors)

The goal in bodybuilding is to use the absolute minimum effective dose to keep prolactin in the low-normal range, NOT to crash it to zero. Zero prolactin destroys immune function, mood, and recovery.

• Preventative Dose: 0.25mg (half a pill) taken once every 10 to 14 days. Because of the ultra-long half-life, taking it twice a week on cycle is usually massive overkill and leads to side effects.
• Reactive Dose (If Prolactin Gyno or Libido Loss Occurs): 0.25mg taken twice a week for 2 weeks to rapidly crash the prolactin, followed by a maintenance dose of 0.25mg every 14 days.
• Blood Work is Mandatory: Prolactin levels must be checked via a sensitive blood assay. If prolactin is in the 2-15 ng/mL range (male normal), cabergoline is not needed. If it rises above 20 ng/mL, a micro-dose is implemented.

Crucial Note: Never use cabergoline as a routine “on-cycle” support unless you are actively using 19-nor steroids. For aromatizing steroids (like Testosterone), an Aromatase Inhibitor is the correct tool, as Testosterone does not spike prolactin.

---

Chapter 9: Cabergoline vs. Pramipexole vs. Bromocriptine

To truly understand when to utilize cabergoline, it must be contrasted with other dopamine agonists.

Cabergoline vs. Bromocriptine

• Selectivity: Bromocriptine is an ergot derivative that non-selectively agonizes D1, D2, and various serotonin receptors. cabergoline is highly D2 selective.
• Half-Life: Bromocriptine has a short half-life requiring multiple daily doses. cabergoline requires at most twice-weekly dosing.
• Side Effects: Bromocriptine causes severe, debilitating nausea and dizziness. cabergoline is vastly better tolerated.
• Efficacy: cabergoline normalizes prolactin in a higher percentage of patients and is effective in Bromocriptine-resistant prolactinomas. cabergoline is universally preferred.

Cabergoline vs. Pramipexole (Mirapex)

• Class: Pramipexole is a non-ergoline D3-preferring agonist.
• Bodybuilding Use: In the underground steroid community, Pramipexole is sometimes used as an alternative to cabergoline for prolactin control.
• Side Effects: Pramipexole has a significantly higher incidence of severe impulse control disorders (pathological gambling/hypersexuality), extreme nausea, and neuroleptic malignant syndrome upon withdrawal. While it does not carry the 5-HT2B cardiac valvulopathy risk of cabergoline, its psychiatric side-effect profile makes it generally less desirable for on-cycle prolactin management.

---

Chapter 10: Sourcing Wholesale Cabergoline: Quality, Purity, and Supply Chain Integrity

For B2B buyers, research chemical companies, compounding pharmacies, and international distributors, sourcing wholesale cabergoline presents unique and critical manufacturing challenges.

Because the active dose is incredibly small (0.5mg per pill), the risk of dose non-uniformity is exceptionally high. In the context of a drug that affects the heart and brain, a pill containing a “hot spot” of 2.0mg of cabergoline could trigger an acute psychotic episode, severe orthostatic collapse, or dangerous valvular stimulation.

At Wholesale China Peptides (https://wholesalechinapeptides.com/), we recognize that safety relies on absolute chemical precision. When sourcing wholesale cabergoline, buyers must demand the following hallmarks of authenticity and quality:

1. Unyielding Third-Party Analytical Testing

Every single batch of wholesale cabergoline API or finished pills must be accompanied by a Certificate of Analysis (COA) from an independent, GMP-certified analytical laboratory.

• High-Performance Liquid Chromatography (HPLC): This verifies the purity of the powder. A premium batch must test at 98% to 99%+ purity. HPLC identifies impurities and residual solvents from synthesis.
• Mass Spectrometry (MS): Used to confirm the molecular weight (451.60 g/mol) and exact identity of the compound, definitively proving the powder is cabergoline and not Bromocriptine or an inert filler.
• Content Uniformity Testing (Pharmacopeial Standards): For 0.5mg pills, standard weight variation is useless. The analytical lab must individually assay 10-30 pills from a batch using HPLC to ensure that every single pill contains between 90% and 110% of the stated 0.5mg dose. This is the most critical test for wholesale cabergoline.

2. cGMP Manufacturing Standards and Geometric Dilution

The facility synthesizing the API and pressing the pills must adhere to Current Good Manufacturing Practices (cGMP).

1. The 1kg of cabergoline API cannot be simply thrown into a 500kg vat of excipient. It will clump immediately.
2. It must undergo Geometric Dilution: The API is mixed with an equal volume of excipient. That mixture is then mixed with an equal volume of excipient, over multiple stages, until the 0.5mg is perfectly dispersed.
3. Wholesale buyers must audit their tableting facilities to ensure proper V-blending and geometric dilution protocols are utilized to guarantee absolute dosing consistency.

3. Secure B2B Logistics and Storage

cabergoline pills and API must be stored in airtight, light-resistant containers at controlled room temperature. The molecule is sensitive to light and moisture. Exposure to high humidity can cause the hygroscopic excipients to degrade, altering the dissolution rate and causing the micro-dosed API to migrate within the tablet. A premium wholesale supplier will provide temperature-controlled, discreet, and fully tracked international shipping to protect the integrity of the chemical and the commercial privacy of the buyer.

By partnering with Wholesale China Peptides, you align with a supplier that prioritizes chemical truth, rigorous analytical verification, and professional B2B service, ensuring your cabergoline is unadulterated, precisely blended, and exactly specified.

---

Chapter 11: The Legal Status of Cabergoline

The regulatory status of cabergoline is strict across the globe, and wholesale buyers must maintain absolute compliance with local and international law.

United States

In the US, cabergoline is classified as a prescription-only drug. It is not a scheduled controlled substance (like narcotics or anabolic steroids), meaning simple possession without a prescription is generally a lesser offense, but manufacturing, distributing, or selling it without DEA and FDA licensing is a federal crime. It is legally available only via a physician’s prescription for hyperprolactinemia.

United Kingdom and Europe

In the UK, cabergoline is a Prescription-Only Medicine (POM). It is not a controlled drug. However, supplying it without proper authorization is illegal. Across the EU, it is heavily regulated as a medicinal product requiring strict pharmaceutical importation licenses for bulk APIs.

Anti-Doping Regulations (WADA)

cabergoline occupies a unique space in anti-doping. While it is not explicitly banned as a performance-enhancing drug (it does not build muscle), its use is intrinsically linked to the consumption of banned anabolic steroids (Trenbolone/Nandrolone). Furthermore, because it lowers prolactin and enhances dopaminergic drive, it could theoretically be argued to provide an unfair psychological or recovery advantage. Athletes subject to testing should treat cabergoline as highly risky from a compliance standpoint.

Research and API Exemption

For legitimate research chemical suppliers and analytical laboratories, cabergoline can often be legally purchased in raw API powder or pill form strictly for in vitro or in vivo laboratory research, provided it is explicitly labeled “Not for Human Consumption” and proper end-user documentation is signed. Wholesale China Peptides operates within the bounds of international research chemical supply laws, and all bulk buyers must verify their local jurisdictional requirements before purchasing.

Disclaimer: This article is intended strictly for educational, informational, and research purposes. Wholesale China Peptides does not condone, promote, or facilitate the illegal use of prescription medications. Cabergoline is a potent psychoactive and cardiovascular-affecting compound. Always consult legal counsel and medical professionals before handling or distributing this compound.

---

Chapter 12: Frequently Asked Questions (FAQ) About Cabergoline

Q1: Can I use Cabergoline to control estrogenic gyno from Testosterone?
A: No. This is a massive and dangerous misconception in the bodybuilding community. Testosterone aromatizes into estrogen, which causes estrogenic gyno. cabergoline only lowers prolactin. It will do absolutely nothing to stop estrogenic gyno or water retention from Testosterone. For testosterone, you need an Aromatase Inhibitor (like Anastrozole) or a SERM (like Tamoxifen). cabergoline is strictly for 19-nor (Trenbolone/Deca) prolactin issues.

Q2: Why is Cabergoline called the “sex drug”?
A: Because high prolactin is the primary neurochemical that suppresses libido and causes the refractory period after orgasm. By crushing prolactin to near-zero, cabergoline drastically reduces the refractory period (allowing for multiple orgasms in rapid succession) and intensely enhances dopaminergic arousal. However, using it solely for this purpose without a medical need is dangerous due to impulse control risks.

Q3: Can I take Cabergoline every day like an AI?
A: Absolutely not. cabergoline has a 65-hour half-life. If you take it daily, it will accumulate to toxic levels in your bloodstream within a week, leading to severe depression, orthostatic hypotension, and potential cardiac stress. It must be dosed once or twice a week at most.

Q4: What happens if I crash my prolactin to zero?
A: Prolactin is not a “junk” hormone; it is necessary for immune function, neurogenesis in the brain, and maintaining myelin sheaths on nerves. Crashing prolactin to zero can lead to severe anhedonia (inability to feel pleasure), depression, anxiety, hair loss, and weakened immunity. Always use the minimum effective dose.

Q5: Does Cabergoline cause heart valve damage?
A: At high, chronic doses (3mg+/day used for Parkinson’s), yes, it agonizes 5-HT2B receptors and causes fibrotic cardiac valvulopathy. At the micro-doses used for hyperprolactinemia or on-cycle bodybuilding (0.25mg to 0.5mg per week), the risk is virtually non-existent. However, long-term users should still obtain occasional echocardiograms.

Q6: Why do I feel sick and dizzy after taking Cabergoline?
A: Stimulation of the D2 receptors in the chemoreceptor trigger zone causes nausea, and peripheral vasodilation causes a drop in blood pressure. To mitigate this, always take cabergoline with a large, high-carbohydrate meal right before going to sleep. The food slows absorption, and lying down prevents orthostatic dizziness.

Q7: How can I ensure my Cabergoline pills are accurately dosed?
A: Because 0.5mg is a micro-dose, you cannot trust underground labs without proof of content uniformity. Only purchase from wholesale suppliers like Wholesale China Peptides who provide third-party HPLC and Mass Spec COAs, and who specifically test for Content Uniformity across the batch to ensure there are no dangerous “hot spots” in the tablets.

---

Conclusion

cabergoline stands as one of the most vital and precisely targeted pharmacological agents in modern endocrinology. From its clinical role in non-invasively shrinking pituitary tumors and restoring fertility, to its indispensable application in rescuing sexual function and halting progestogenic gynecomastia in the performance enhancement community, its high D2 selectivity and ultra-long half-life make it a triumph of pharmacological engineering.

However, its extreme potency and systemic dopaminergic effects demand extreme respect. The delicate balance between restoring libido and triggering impulse control disorders, or between shrinking a tumor and inducing cardiac valvulopathy, necessitates precise, minimal dosing, comprehensive blood work monitoring, and absolute chemical purity.

For the research community, compounding pharmacies, and B2B wholesale buyers, guaranteeing the quality and dose uniformity of cabergoline is a matter of clinical and commercial integrity. Sub-standard APIs, residual solvents, and poorly blended pills creating “hot spots” are unacceptable when dealing with a 0.5mg psychoactive endocrine modulator. At Wholesale China Peptides (https://wholesalechinapeptides.com/), we guarantee the highest standard of chemical integrity. Our wholesale cabergoline is backed by rigorous, third-party analytical testing, cGMP-certified geometric blending, and uncompromising supply chain transparency.

When your research, formulation, or supply demands require the absolute pinnacle of dopamine agonist pharmacology, trust only verified, authenticated cabergoline. Explore our wholesale catalog today and partner with a supplier that prioritizes scientific truth, chemical purity, and professional integrity above all else.